Literature DB >> 12888626

Implications of ventricular arrhythmia vulnerability during murine electrophysiology studies.

Colin T Maguire1, Hiroko Wakimoto, Vickas V Patel, Peter E Hammer, Kimberlee Gauvreau, Charles I Berul.   

Abstract

Programmed ventricular stimulation is being performed for the provocation of ventricular arrhythmias in genetically engineered mice. Despite the high level of interest in this area of translational research, little attention has been given to differentiating between selectivity and specificity of induced ventricular tachycardia (VT) in phenotypically normal mice. We aimed to assess factors that may enhance inducibility of VT in wild-type (WT) mice. In vivo intracardiac electrophysiological studies (EPS) were performed in 230 WT mice of 4 strains. An octapolar electrode catheter was inserted into a jugular vein and advanced to the right atrium and ventricle. Baseline ventricular conduction, refractoriness, and arrhythmia inducibility were assessed using programmed electrical stimulation (PES) and burst pacing. We found that nonsustained VT (> or =4 beats) was inducible in 68/230 (30%) mice. Duration of VT was 1.6 +/- 2.4 s, and the longest episode lasted 24 s. VT inducibility differed by strain and age. Ventricular effective refractory period (VERP) was shorter in mice with inducible VT (44 +/- 12 ms) compared with noninducible mice (61 +/- 16 ms, P < 0.001). VERP increased with age (P < 0.001), albeit with strain-related variability. We conclude that nonsustained VT in WT mice is reproducibly inducible and common. Genetic background variability may predispose certain strains to a higher incidence of arrhythmia induction. EPS methods impact prevalence and specificity of inducible VT. Increased VT inducibility was seen with shorter coupling intervals and application of tightly coupled extrastimuli techniques. These factors should be carefully considered when analyzing PES and burst pacing data in murine models to minimize false positives and optimize accuracy.

Entities:  

Mesh:

Year:  2003        PMID: 12888626     DOI: 10.1152/physiolgenomics.00034.2003

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  31 in total

1.  Absence of the inhibitory G-protein Galphai2 predisposes to ventricular cardiac arrhythmia.

Authors:  Zia Zuberi; Muriel Nobles; Sonia Sebastian; Alex Dyson; Shiang Y Lim; Ross Breckenridge; Lutz Birnbaumer; Andrew Tinker
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-05-21

2.  Cardiac electrophysiology and the susceptibility to sustained ventricular tachycardia in intact, conscious mice.

Authors:  Heidi L Lujan; Stephen E DiCarlo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-21       Impact factor: 4.733

3.  Bcl10 mediates angiotensin II-induced cardiac damage and electrical remodeling.

Authors:  Lajos Markó; Norbert Henke; Joon-Keun Park; Bastian Spallek; Fatimunnisa Qadri; András Balogh; Ingrid J Apel; Katherine I Oravecz-Wilson; Mira Choi; Lukasz Przybyl; Katrina J Binger; Nadine Haase; Nicola Wilck; Arnd Heuser; Verena Fokuhl; Jürgen Ruland; Peter C Lucas; Linda M McAllister-Lucas; Friedrich C Luft; Ralf Dechend; Dominik N Müller
Journal:  Hypertension       Date:  2014-09-02       Impact factor: 10.190

4.  Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis.

Authors:  Laura S Danielson; David S Park; Noemi Rotllan; Aranzazu Chamorro-Jorganes; Maria V Guijarro; Carlos Fernandez-Hernando; Glenn I Fishman; Colin K L Phoon; Eva Hernando
Journal:  FASEB J       Date:  2012-12-27       Impact factor: 5.191

5.  Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia.

Authors:  Cordula M Wolf; Ivan P G Moskowitz; Scott Arno; Dorothy M Branco; Christopher Semsarian; Scott A Bernstein; Michael Peterson; Michael Maida; Gregory E Morley; Glenn Fishman; Charles I Berul; Christine E Seidman; J G Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-06       Impact factor: 11.205

6.  Constitutively active phosphatase inhibitor-1 improves cardiac contractility in young mice but is deleterious after catecholaminergic stress and with aging.

Authors:  Katrin Wittköpper; Larissa Fabritz; Stefan Neef; Katharina R Ort; Clemens Grefe; Bernhard Unsöld; Paulus Kirchhof; Lars S Maier; Gerd Hasenfuss; Dobromir Dobrev; Thomas Eschenhagen; Ali El-Armouche
Journal:  J Clin Invest       Date:  2010-01-11       Impact factor: 14.808

7.  Heterogeneous expression of repolarizing, voltage-gated K+ currents in adult mouse ventricles.

Authors:  Sylvain Brunet; Franck Aimond; Huilin Li; Weinong Guo; Jodene Eldstrom; David Fedida; Kathryn A Yamada; Jeanne M Nerbonne
Journal:  J Physiol       Date:  2004-06-11       Impact factor: 5.182

8.  Gap junction remodeling and spironolactone-dependent reverse remodeling in the hypertrophied heart.

Authors:  Jiaxiang Qu; Frank M Volpicelli; Luis I Garcia; Nefthi Sandeep; Jie Zhang; Lucrecia Márquez-Rosado; Paul D Lampe; Glenn I Fishman
Journal:  Circ Res       Date:  2008-12-18       Impact factor: 17.367

9.  Sodium current properties of primary skeletal myocytes and cardiomyocytes derived from different mouse strains.

Authors:  M Mille; X Koenig; E Zebedin; P Uhrin; R Cervenka; H Todt; K Hilber
Journal:  Pflugers Arch       Date:  2008-08-13       Impact factor: 3.657

10.  Optogenetic defibrillation terminates ventricular arrhythmia in mouse hearts and human simulations.

Authors:  Tobias Bruegmann; Patrick M Boyle; Christoph C Vogt; Thomas V Karathanos; Hermenegild J Arevalo; Bernd K Fleischmann; Natalia A Trayanova; Philipp Sasse
Journal:  J Clin Invest       Date:  2016-09-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.